Istanbul University Cerrahpasa
Istanbul, Turkey (Türkiye)
NCT Number: NCT05356273
Background: It has been reported in the current literature that massage has various positive physiological effects on the newborn. Also baby massage; It increases the collection and excretion of waste products such as bilirubin by accelerating the flow of blood, lymph and tissue fluids. Our aim is to investigate the effect of infant massage on hyperbilirubinemia in newborns receiving phototherapy.
Method: The population of the study consisted of babies who were hospitalized in Istanbul Haseki Training and Research Hospital Neonatal Intensive Care Unit between October 2021 and January 2022 and needed phototherapy. Transcutaneous bilirubin device and data collection form were used to obtain the data. 61 newborns who met the study criteria were randomly divided into experimental (n=30) and control (n=31) groups. Phototherapy was applied to all babies twice a day. In addition to phototherapy, infant massage was applied to the experimental group for 10 minutes just before the phototherapy. Bilirubin level measurements were made 2 hours after the end of phototherapy for both groups. Diaper changes for both groups were carried out 8 times a day, every 3 hours.
Looking for future studies?
Notify Me1 day–28 day
All sexes
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Starting from the baby's face first, then the abdomen and chest, back, upper extremities and finally the lower extremities were massaged with semi-circular movements, respectively.
Time frame: 72 hours
decreasing bilirubin levels within intervention times
Time frame: 72 hours
increasing stool frequency within intervention times
Istanbul University - Cerrahpasa
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06921330
ABO Incompatibility, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT06209489
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Karabük, Turkey (Türkiye)
View Trial DetailsNCT06645158
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Guangzhou, Guangdong, China
View Trial DetailsNCT06324799
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Mersin, Turkey (Türkiye)
View Trial Details